| scholarly article | Q13442814 |
| P50 | author | Massimo Zeviani | Q28321912 |
| Costanza Lamperti | Q28321919 | ||
| Daniele Ghezzi | Q30093362 | ||
| Federica Invernizzi | Q42258130 | ||
| Marina Mora | Q47504621 | ||
| Francesca Novara | Q55692638 | ||
| Orsetta Zuffardi | Q56721638 | ||
| Graziella Uziel | Q80073138 | ||
| P2093 | author name string | Irina Sevrioukova | |
| Pio D'Adamo | |||
| P2860 | cites work | Molecular characterization of mitochondrial apoptosis-inducing factor | Q22001452 |
| Human Na(+)/H(+) exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria | Q24293474 | ||
| Export of mitochondrial AIF in response to proapoptotic stimuli depends on processing at the intermembrane space | Q24298363 | ||
| The crystal structure of the mouse apoptosis-inducing factor AIF | Q27638885 | ||
| DNA binding is required for the apoptogenic action of apoptosis inducing factor | Q27639548 | ||
| Redox-Linked Conformational Dynamics in Apoptosis-Inducing Factor | Q27655498 | ||
| AIF: not just an apoptosis-inducing factor | Q28257046 | ||
| AIF suppresses chemical stress-induced apoptosis and maintains the transformed state of tumor cells | Q33910919 | ||
| Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy | Q34150861 | ||
| The harlequin mouse mutation downregulates apoptosis-inducing factor | Q34152182 | ||
| Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation | Q34206865 | ||
| Mitochondrial disease | Q34543745 | ||
| Dissociating the dual roles of apoptosis-inducing factor in maintaining mitochondrial structure and apoptosis | Q35017918 | ||
| Mitochondrial fission in apoptosis | Q36198122 | ||
| Mitochondrial release of apoptosis-inducing factor occurs downstream of cytochrome c release in response to several proapoptotic stimuli | Q36325547 | ||
| Mitochondrial medicine: a metabolic perspective on the pathology of oxidative phosphorylation disorders | Q36363369 | ||
| Apoptosis-inducing factor: vital and lethal | Q36452233 | ||
| Eclipsed distribution: a phenomenon of dual targeting of protein and its significance | Q36875701 | ||
| Mitochondrial and nuclear cross talk in cell death: parthanatos | Q37348568 | ||
| Batteries not included: diagnosis and management of mitochondrial disease. | Q37385079 | ||
| Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos | Q37426834 | ||
| Outer mitochondrial membrane localization of apoptosis-inducing factor: mechanistic implications for release | Q37443963 | ||
| AIF deficiency compromises oxidative phosphorylation | Q37671807 | ||
| Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria | Q45182256 | ||
| Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor | Q46155629 | ||
| Cysteine protease inhibition prevents mitochondrial apoptosis-inducing factor (AIF) release | Q46525695 | ||
| OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion | Q46789094 | ||
| Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans | Q47069202 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrial encephalomyopathy | Q6881866 |
| apoptotic process | Q14599311 | ||
| P304 | page(s) | 639-649 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | American Journal of Human Genetics | Q4744249 |
| P1476 | title | Severe X-linked mitochondrial encephalomyopathy associated with a mutation in apoptosis-inducing factor | |
| P478 | volume | 86 |
| Q55435412 | A disease-associated Aifm1 variant induces severe myopathy in knockin mice. |
| Q85018665 | A human mitochondriopathy caused by AIF mutation |
| Q47702623 | A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation. |
| Q38502090 | A novel AIFM1 mutation expands the phenotype to an infantile motor neuron disease |
| Q55286697 | A novel CHCHD10 mutation implicates a Mia40-dependent mitochondrial import deficit in ALS. |
| Q36193560 | A role for apoptosis-inducing factor in T cell development |
| Q30397903 | A slowly progressive mitochondrial encephalomyopathy widens the spectrum of AIFM1 disorders |
| Q36270879 | AIF inhibits tumor metastasis by protecting PTEN from oxidation |
| Q48262587 | AIF loss deregulates hematopoiesis and reveals different adaptive metabolic responses in bone marrow cells and thymocytes. |
| Q62016936 | AIF promotes a JNK1-mediated cadherin switch independently of respiratory chain stabilization |
| Q36724691 | AIF, reactive oxygen species, and neurodegeneration: a "complex" problem |
| Q37678110 | AIFM1 mutation presenting with fatal encephalomyopathy and mitochondrial disease in an infant |
| Q57299773 | Apoptosis inducing factor deficiency causes retinal photoreceptor degeneration. The protective role of the redox compound methylene blue |
| Q55265243 | Apoptosis-Inducing Factor (AIF) in Physiology and Disease: The Tale of a Repented Natural Born Killer. |
| Q35660665 | Apoptosis-inducing Factor (AIF) and Its Family Member Protein, AMID, Are Rotenone-sensitive NADH:Ubiquinone Oxidoreductases (NDH-2). |
| Q39526385 | Apoptosis-inducing factor is a target gene of C/EBPα and participates in adipocyte differentiation |
| Q34987223 | Apoptosis-inducing factor: structure, function, and redox regulation |
| Q40812036 | Assessing apoptosis gene expression profiling with a PCR array in the hippocampus of Ts65Dn mice |
| Q35997632 | Basal metabolic state governs AIF-dependent growth support in pancreatic cancer cells. |
| Q24305311 | Cowchock syndrome is associated with a mutation in apoptosis-inducing factor |
| Q92890014 | Decreased expression of apoptosis-inducing factor in renal cell carcinoma is associated with poor prognosis and reduced postoperative survival |
| Q46150120 | Defining NADH-Driven Allostery Regulating Apoptosis-Inducing Factor |
| Q47351811 | Detergent Insoluble Proteins and Inclusion Body-Like Structures Immunoreactive for PRKDC/DNA-PK/DNA-PKcs, FTL, NNT, and AIFM1 in the Amygdala of Cognitively Impaired Elderly Persons. |
| Q64898477 | Diagnostic Yields of Trio-WES Accompanied by CNVseq for Rare Neurodevelopmental Disorders. |
| Q30668621 | Disease-Causing SDHAF1 Mutations Impair Transfer of Fe-S Clusters to SDHB |
| Q46832645 | Early prenatal ventriculomegaly due to an AIFM1 mutation identified by linkage analysis and whole exome sequencing |
| Q34148592 | Exome sequencing identifies ACAD9 mutations as a cause of complex I deficiency |
| Q51461233 | Heterozygous mutation in the X chromosomal NDUFA1 gene in a girl with complex I deficiency. |
| Q28077589 | Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration |
| Q46039232 | LKB1-regulated adaptive mechanisms are essential for neuronal survival following mitochondrial dysfunction. |
| Q38617364 | Leigh syndrome: One disorder, more than 75 monogenic causes |
| Q36293830 | Loss of apoptosis-inducing factor critically affects MIA40 function. |
| Q35591692 | Maternally inherited mitochondrial DNA disease in consanguineous families |
| Q37909459 | Mechanisms of mitochondrial diseases |
| Q36187248 | Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4. |
| Q37120693 | Mitochondria Biogenesis and Bioenergetics Gene Profiles in Isogenic Prostate Cells with Different Malignant Phenotypes |
| Q52621890 | Mitochondrial Agents for Bipolar Disorder. |
| Q30910075 | Mitochondrial Complex III Deficiency Caused by TTC19 Defects: Report of a Novel Mutation and Review of Literature. |
| Q35660977 | Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function |
| Q26769015 | Mitochondrial cytochrome c oxidase deficiency |
| Q37979255 | Mitochondrial disease and epilepsy |
| Q38249965 | Mitochondrial disease associated with complex I (NADH-CoQ oxidoreductase) deficiency |
| Q83827338 | Mitochondrial diseases |
| Q95554206 | Mitochondrial diseases |
| Q37890682 | Mitochondrial disorders caused by mutations in respiratory chain assembly factors |
| Q38932389 | Mitochondrial disulfide relay and its substrates: mechanisms in health and disease. |
| Q38570577 | Mitochondrial dysfunction and seizures: the neuronal energy crisis |
| Q38736014 | Mitochondrial dysfunction underlies cognitive defects as a result of neural stem cell depletion and impaired neurogenesis. |
| Q38088309 | Mitochondrial epilepsy in pediatric and adult patients |
| Q35754400 | Modeling mitochondrial dysfunctions in the brain: from mice to men. |
| Q34103418 | Mouse studies to shape clinical trials for mitochondrial diseases: high fat diet in Harlequin mice |
| Q30405518 | Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder |
| Q41836048 | Mutations of the mitochondrial-tRNA modifier MTO1 cause hypertrophic cardiomyopathy and lactic acidosis |
| Q33724242 | Neuroglobin gene therapy prevents optic atrophy and preserves durably visual function in Harlequin mice |
| Q31076462 | Neurological Disorders Associated with Striatal Lesions: Classification and Diagnostic Approach. |
| Q34530586 | New perspective in diagnostics of mitochondrial disorders: two years' experience with whole-exome sequencing at a national paediatric centre |
| Q35874918 | Non-apoptotic functions of apoptosis-regulatory proteins |
| Q59360270 | Oxeiptosis-a cell death pathway to mitigate damage caused by radicals |
| Q27312275 | PARP1 gene knock-out increases resistance to retinal degeneration without affecting retinal function. |
| Q42314924 | Paradoxical Inhibition of Glycolysis by Pioglitazone Opposes the Mitochondriopathy Caused by AIF Deficiency |
| Q28579972 | Proteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) gene |
| Q37592358 | Role of apoptosis-inducing factor (Aif) in the T cell lineage |
| Q35955745 | Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress |
| Q50316569 | Spondyloepimetaphyseal dysplasia with neurodegeneration associated with AIFM1 mutation - a novel phenotype of the mitochondrial disease. |
| Q38280117 | Strategies for treating mitochondrial disorders: an update |
| Q36481896 | The enzymatic activity of apoptosis-inducing factor supports energy metabolism benefiting the growth and invasiveness of advanced prostate cancer cells |
| Q98733497 | The human papillomavirus E6 protein targets apoptosis-inducing factor (AIF) for degradation |
| Q34298350 | The optic nerve: a "mito-window" on mitochondrial neurodegeneration |
| Q37915809 | The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases. |
| Q28505379 | Tissue-specific splicing of an Ndufs6 gene-trap insertion generates a mitochondrial complex I deficiency-specific cardiomyopathy |
| Q28118796 | Variant non ketotic hyperglycinemia is caused by mutations in LIAS, BOLA3 and the novel gene GLRX5 |
| Q55027001 | WAH-1/AIF regulates mitochondrial oxidative phosphorylation in the nematode Caenorhabditis elegans. |
| Q92684439 | Whole exome sequencing identifies a novel variant in an apoptosis-inducing factor gene associated with X-linked recessive hearing loss in a Chinese family |
| Q40156896 | X-linked congenital ptosis and associated intellectual disability, short stature, microcephaly, cleft palate, digital and genital abnormalities define novel Xq25q26 duplication syndrome. |
| Q47124322 | X-linked hypomyelination with spondylometaphyseal dysplasia (H-SMD) associated with mutations in AIFM1. |
Search more.